The forecasted mortality rates for bladder malignant neoplasms in the UK indicate a gradual decline from 7.0 deaths per 100,000 persons in 2024 to 6.8 by 2028. In 2023, the rate stood at 7.0, highlighting a consistent level moving into 2024, with reductions becoming apparent from 2026 onwards. Year-on-year variations show no change from 2024 to 2025, a slight 1.4% decrease in 2026, and similar subsequent yearly declines continue through 2028. The compound annual growth rate (CAGR) over the five years reveals an average annual decrease of approximately 0.86%, indicating a positive trend in reducing mortality rates.
Future trends to watch for include advancements in early detection and treatment methods for bladder cancer, which could accelerate the decline in mortality rates. Additionally, public health initiatives focusing on risk factors such as smoking cessation and chemical exposure reduction may further impact these rates favorably.
